ERCC1 and lung cancer: In these studies, the combination of cisplatin and curcumin or emodin produced significantly lower ERCC1 mRNA levels when compared with cisplatin alone, indicating that these products can downregulate both protein and mRNA expression of ERCC1 in these human lung cancer cell lines.